Titre : Caractéristiques des études épidémiologiques

Caractéristiques des études épidémiologiques : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Qu'est-ce qu'une étude de cohorte ?

Une étude de cohorte suit un groupe sur le temps pour observer l'apparition de maladies.
Étude de cohorte Épidémiologie
#2

Comment une étude cas-témoins est-elle réalisée ?

Elle compare des individus malades à des témoins sains pour identifier des facteurs de risque.
Étude cas-témoins Facteurs de risque
#3

Quelle est l'importance des études transversales ?

Elles évaluent la prévalence d'une maladie à un moment donné dans une population.
Étude transversale Prévalence
#4

Qu'est-ce qu'une étude longitudinale ?

C'est une étude qui observe les mêmes sujets sur une période prolongée pour des changements.
Étude longitudinale Suivi
#5

Quel est le rôle des essais cliniques ?

Ils testent l'efficacité et la sécurité de nouveaux traitements sur des groupes de patients.
Essai clinique Traitement

Symptômes 5

#1

Comment les symptômes sont-ils collectés dans les études ?

Ils sont souvent recueillis via des questionnaires ou des entretiens avec les participants.
Symptômes Questionnaire
#2

Quelle est la méthode d'évaluation des symptômes ?

Les échelles de mesure standardisées sont utilisées pour quantifier l'intensité des symptômes.
Évaluation des symptômes Échelle de mesure
#3

Pourquoi est-il important de définir les symptômes ?

Une définition claire aide à standardiser les études et à comparer les résultats entre elles.
Définition des symptômes Standardisation
#4

Comment les symptômes influencent-ils les résultats ?

Ils peuvent affecter la qualité de vie et la réponse au traitement, influençant les conclusions.
Qualité de vie Résultats cliniques
#5

Quels outils mesurent les symptômes ?

Des outils comme le VAS (Visual Analog Scale) ou le SF-36 sont couramment utilisés.
Outils de mesure Évaluation

Prévention 5

#1

Quelles stratégies de prévention sont courantes ?

Les campagnes de sensibilisation et les vaccinations sont des stratégies clés de prévention.
Prévention Vaccination
#2

Comment évaluer l'efficacité des programmes de prévention ?

On utilise des études avant-après pour mesurer l'impact des interventions préventives.
Programmes de prévention Études avant-après
#3

Quel rôle joue l'éducation dans la prévention ?

L'éducation sensibilise les populations aux risques et aux comportements sains pour prévenir les maladies.
Éducation à la santé Comportements sains
#4

Comment les facteurs environnementaux influencent-ils la prévention ?

Les conditions environnementales peuvent affecter l'accès aux soins et les comportements préventifs.
Facteurs environnementaux Accès aux soins
#5

Pourquoi la surveillance épidémiologique est-elle essentielle ?

Elle permet de détecter les épidémies et d'évaluer l'efficacité des mesures de prévention.
Surveillance épidémiologique Épidémies

Traitements 5

#1

Comment les traitements sont-ils évalués dans les études ?

Ils sont comparés à un groupe témoin pour déterminer leur efficacité et leurs effets secondaires.
Évaluation des traitements Efficacité
#2

Quel est l'impact des traitements sur les résultats ?

Les traitements peuvent améliorer les résultats de santé, mais des effets indésirables peuvent survenir.
Résultats de santé Effets indésirables
#3

Quelles sont les méthodes de randomisation ?

La randomisation assure que les groupes de traitement sont comparables, minimisant les biais.
Randomisation Biais
#4

Pourquoi les études de traitement sont-elles cruciales ?

Elles fournissent des preuves sur l'efficacité des interventions médicales et des protocoles.
Interventions médicales Preuves
#5

Comment les effets à long terme des traitements sont-ils étudiés ?

Des études de suivi à long terme évaluent la durabilité des effets des traitements.
Suivi à long terme Durabilité

Complications 5

#1

Comment les complications sont-elles identifiées dans les études ?

Elles sont souvent rapportées par les participants ou détectées par des examens médicaux.
Complications Examens médicaux
#2

Quel est l'impact des complications sur les résultats ?

Les complications peuvent aggraver l'état de santé et influencer les décisions de traitement.
Impact des complications Décisions de traitement
#3

Comment les complications sont-elles classées ?

Elles sont classées par gravité et type, facilitant l'analyse des données épidémiologiques.
Classification des complications Analyse des données
#4

Pourquoi est-il important de suivre les complications ?

Le suivi aide à comprendre les effets à long terme des maladies et des traitements.
Suivi des complications Effets à long terme
#5

Quelles méthodes préviennent les complications ?

Des protocoles de soins et des interventions précoces peuvent réduire le risque de complications.
Prévention des complications Interventions précoces

Facteurs de risque 5

#1

Comment les facteurs de risque sont-ils identifiés ?

Ils sont souvent déterminés par des études épidémiologiques analysant les données de santé.
Facteurs de risque Analyse des données
#2

Quel est l'impact des facteurs de risque sur la santé ?

Les facteurs de risque augmentent la probabilité de développer certaines maladies ou conditions.
Santé Probabilité
#3

Comment les facteurs de risque sont-ils mesurés ?

Ils sont mesurés par des questionnaires, des tests biologiques ou des examens cliniques.
Mesure des facteurs de risque Questionnaires
#4

Pourquoi est-il crucial d'étudier les facteurs de risque ?

Comprendre les facteurs de risque aide à développer des stratégies de prévention efficaces.
Stratégies de prévention Compréhension
#5

Quels types de facteurs de risque existent ?

Ils peuvent être biologiques, comportementaux, environnementaux ou socio-économiques.
Types de facteurs de risque Environnement
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Caractéristiques des études épidémiologiques : Questions médicales les plus fréquentes", "headline": "Caractéristiques des études épidémiologiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Caractéristiques des études épidémiologiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-30", "dateModified": "2025-02-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Caractéristiques des études épidémiologiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Méthodes épidémiologiques", "url": "https://questionsmedicales.fr/mesh/D004812", "about": { "@type": "MedicalCondition", "name": "Méthodes épidémiologiques", "code": { "@type": "MedicalCode", "code": "D004812", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Études cliniques comme sujet", "alternateName": "Clinical Studies as Topic", "url": "https://questionsmedicales.fr/mesh/D000068456", "about": { "@type": "MedicalCondition", "name": "Études cliniques comme sujet", "code": { "@type": "MedicalCode", "code": "D000068456", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Essais cliniques comme sujet", "alternateName": "Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D002986", "about": { "@type": "MedicalCondition", "name": "Essais cliniques comme sujet", "code": { "@type": "MedicalCode", "code": "D002986", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Essais cliniques adaptatifs comme sujet", "alternateName": "Adaptive Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D000075522", "about": { "@type": "MedicalCondition", "name": "Essais cliniques adaptatifs comme sujet", "code": { "@type": "MedicalCode", "code": "D000075522", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.100" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques de phase I comme sujet", "alternateName": "Clinical Trials, Phase I as Topic", "url": "https://questionsmedicales.fr/mesh/D017321", "about": { "@type": "MedicalCondition", "name": "Essais cliniques de phase I comme sujet", "code": { "@type": "MedicalCode", "code": "D017321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.200" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques de phase II comme sujet", "alternateName": "Clinical Trials, Phase II as Topic", "url": "https://questionsmedicales.fr/mesh/D017322", "about": { "@type": "MedicalCondition", "name": "Essais cliniques de phase II comme sujet", "code": { "@type": "MedicalCode", "code": "D017322", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.210" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques de phase III comme sujet", "alternateName": "Clinical Trials, Phase III as Topic", "url": "https://questionsmedicales.fr/mesh/D017326", "about": { "@type": "MedicalCondition", "name": "Essais cliniques de phase III comme sujet", "code": { "@type": "MedicalCode", "code": "D017326", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.220" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques de phase IV comme sujet", "alternateName": "Clinical Trials, Phase IV as Topic", "url": "https://questionsmedicales.fr/mesh/D017327", "about": { "@type": "MedicalCondition", "name": "Essais cliniques de phase IV comme sujet", "code": { "@type": "MedicalCode", "code": "D017327", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.230" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques contrôlés comme sujet", "alternateName": "Controlled Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D018849", "about": { "@type": "MedicalCondition", "name": "Essais cliniques contrôlés comme sujet", "code": { "@type": "MedicalCode", "code": "D018849", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Essais contrôlés non randomisés comme sujet", "alternateName": "Non-Randomized Controlled Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D065228", "about": { "@type": "MedicalCondition", "name": "Essais contrôlés non randomisés comme sujet", "code": { "@type": "MedicalCode", "code": "D065228", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.250" } } }, { "@type": "MedicalWebPage", "name": "Essais contrôlés randomisés comme sujet", "alternateName": "Randomized Controlled Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D016032", "about": { "@type": "MedicalCondition", "name": "Essais contrôlés randomisés comme sujet", "code": { "@type": "MedicalCode", "code": "D016032", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Essais d'équivalence comme sujet", "alternateName": "Equivalence Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D000074099", "about": { "@type": "MedicalCondition", "name": "Essais d'équivalence comme sujet", "code": { "@type": "MedicalCode", "code": "D000074099", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.250" } } }, { "@type": "MedicalWebPage", "name": "Analyse en intention de traitement", "alternateName": "Intention to Treat Analysis", "url": "https://questionsmedicales.fr/mesh/D057194", "about": { "@type": "MedicalCondition", "name": "Analyse en intention de traitement", "code": { "@type": "MedicalCode", "code": "D057194", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.500" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques pragmatiques comme sujet", "alternateName": "Pragmatic Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D064792", "about": { "@type": "MedicalCondition", "name": "Essais cliniques pragmatiques comme sujet", "code": { "@type": "MedicalCode", "code": "D064792", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Essais d'équivalence comme sujet", "alternateName": "Equivalence Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D000074099", "about": { "@type": "MedicalCondition", "name": "Essais d'équivalence comme sujet", "code": { "@type": "MedicalCode", "code": "D000074099", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.250" } } }, { "@type": "MedicalWebPage", "name": "Analyse en intention de traitement", "alternateName": "Intention to Treat Analysis", "url": "https://questionsmedicales.fr/mesh/D057194", "about": { "@type": "MedicalCondition", "name": "Analyse en intention de traitement", "code": { "@type": "MedicalCode", "code": "D057194", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.500" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques pragmatiques comme sujet", "alternateName": "Pragmatic Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D064792", "about": { "@type": "MedicalCondition", "name": "Essais cliniques pragmatiques comme sujet", "code": { "@type": "MedicalCode", "code": "D064792", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Essais contrôlés non randomisés comme sujet", "alternateName": "Non-Randomized Controlled Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D065228", "about": { "@type": "MedicalCondition", "name": "Essais contrôlés non randomisés comme sujet", "code": { "@type": "MedicalCode", "code": "D065228", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.250" } } }, { "@type": "MedicalWebPage", "name": "Essais contrôlés randomisés comme sujet", "alternateName": "Randomized Controlled Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D016032", "about": { "@type": "MedicalCondition", "name": "Essais contrôlés randomisés comme sujet", "code": { "@type": "MedicalCode", "code": "D016032", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Essais d'équivalence comme sujet", "alternateName": "Equivalence Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D000074099", "about": { "@type": "MedicalCondition", "name": "Essais d'équivalence comme sujet", "code": { "@type": "MedicalCode", "code": "D000074099", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.250" } } }, { "@type": "MedicalWebPage", "name": "Analyse en intention de traitement", "alternateName": "Intention to Treat Analysis", "url": "https://questionsmedicales.fr/mesh/D057194", "about": { "@type": "MedicalCondition", "name": "Analyse en intention de traitement", "code": { "@type": "MedicalCode", "code": "D057194", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.500" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques pragmatiques comme sujet", "alternateName": "Pragmatic Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D064792", "about": { "@type": "MedicalCondition", "name": "Essais cliniques pragmatiques comme sujet", "code": { "@type": "MedicalCode", "code": "D064792", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Essais d'équivalence comme sujet", "alternateName": "Equivalence Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D000074099", "about": { "@type": "MedicalCondition", "name": "Essais d'équivalence comme sujet", "code": { "@type": "MedicalCode", "code": "D000074099", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.250" } } }, { "@type": "MedicalWebPage", "name": "Analyse en intention de traitement", "alternateName": "Intention to Treat Analysis", "url": "https://questionsmedicales.fr/mesh/D057194", "about": { "@type": "MedicalCondition", "name": "Analyse en intention de traitement", "code": { "@type": "MedicalCode", "code": "D057194", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.500" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques pragmatiques comme sujet", "alternateName": "Pragmatic Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D064792", "about": { "@type": "MedicalCondition", "name": "Essais cliniques pragmatiques comme sujet", "code": { "@type": "MedicalCode", "code": "D064792", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.750" } } }, { "@type": "MedicalWebPage", "name": "Études de cas unique comme sujet", "alternateName": "Single-Case Studies as Topic", "url": "https://questionsmedicales.fr/mesh/D000080907", "about": { "@type": "MedicalCondition", "name": "Études de cas unique comme sujet", "code": { "@type": "MedicalCode", "code": "D000080907", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.682" } } } ] }, { "@type": "MedicalWebPage", "name": "Essais cliniques adaptatifs comme sujet", "alternateName": "Adaptive Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D000075522", "about": { "@type": "MedicalCondition", "name": "Essais cliniques adaptatifs comme sujet", "code": { "@type": "MedicalCode", "code": "D000075522", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.100" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques de phase I comme sujet", "alternateName": "Clinical Trials, Phase I as Topic", "url": "https://questionsmedicales.fr/mesh/D017321", "about": { "@type": "MedicalCondition", "name": "Essais cliniques de phase I comme sujet", "code": { "@type": "MedicalCode", "code": "D017321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.200" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques de phase II comme sujet", "alternateName": "Clinical Trials, Phase II as Topic", "url": "https://questionsmedicales.fr/mesh/D017322", "about": { "@type": "MedicalCondition", "name": "Essais cliniques de phase II comme sujet", "code": { "@type": "MedicalCode", "code": "D017322", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.210" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques de phase III comme sujet", "alternateName": "Clinical Trials, Phase III as Topic", "url": "https://questionsmedicales.fr/mesh/D017326", "about": { "@type": "MedicalCondition", "name": "Essais cliniques de phase III comme sujet", "code": { "@type": "MedicalCode", "code": "D017326", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.220" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques de phase IV comme sujet", "alternateName": "Clinical Trials, Phase IV as Topic", "url": "https://questionsmedicales.fr/mesh/D017327", "about": { "@type": "MedicalCondition", "name": "Essais cliniques de phase IV comme sujet", "code": { "@type": "MedicalCode", "code": "D017327", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.230" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques contrôlés comme sujet", "alternateName": "Controlled Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D018849", "about": { "@type": "MedicalCondition", "name": "Essais cliniques contrôlés comme sujet", "code": { "@type": "MedicalCode", "code": "D018849", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Essais contrôlés non randomisés comme sujet", "alternateName": "Non-Randomized Controlled Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D065228", "about": { "@type": "MedicalCondition", "name": "Essais contrôlés non randomisés comme sujet", "code": { "@type": "MedicalCode", "code": "D065228", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.250" } } }, { "@type": "MedicalWebPage", "name": "Essais contrôlés randomisés comme sujet", "alternateName": "Randomized Controlled Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D016032", "about": { "@type": "MedicalCondition", "name": "Essais contrôlés randomisés comme sujet", "code": { "@type": "MedicalCode", "code": "D016032", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Essais d'équivalence comme sujet", "alternateName": "Equivalence Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D000074099", "about": { "@type": "MedicalCondition", "name": "Essais d'équivalence comme sujet", "code": { "@type": "MedicalCode", "code": "D000074099", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.250" } } }, { "@type": "MedicalWebPage", "name": "Analyse en intention de traitement", "alternateName": "Intention to Treat Analysis", "url": "https://questionsmedicales.fr/mesh/D057194", "about": { "@type": "MedicalCondition", "name": "Analyse en intention de traitement", "code": { "@type": "MedicalCode", "code": "D057194", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.500" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques pragmatiques comme sujet", "alternateName": "Pragmatic Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D064792", "about": { "@type": "MedicalCondition", "name": "Essais cliniques pragmatiques comme sujet", "code": { "@type": "MedicalCode", "code": "D064792", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Essais d'équivalence comme sujet", "alternateName": "Equivalence Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D000074099", "about": { "@type": "MedicalCondition", "name": "Essais d'équivalence comme sujet", "code": { "@type": "MedicalCode", "code": "D000074099", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.250" } } }, { "@type": "MedicalWebPage", "name": "Analyse en intention de traitement", "alternateName": "Intention to Treat Analysis", "url": "https://questionsmedicales.fr/mesh/D057194", "about": { "@type": "MedicalCondition", "name": "Analyse en intention de traitement", "code": { "@type": "MedicalCode", "code": "D057194", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.500" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques pragmatiques comme sujet", "alternateName": "Pragmatic Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D064792", "about": { "@type": "MedicalCondition", "name": "Essais cliniques pragmatiques comme sujet", "code": { "@type": "MedicalCode", "code": "D064792", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Essais contrôlés non randomisés comme sujet", "alternateName": "Non-Randomized Controlled Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D065228", "about": { "@type": "MedicalCondition", "name": "Essais contrôlés non randomisés comme sujet", "code": { "@type": "MedicalCode", "code": "D065228", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.250" } } }, { "@type": "MedicalWebPage", "name": "Essais contrôlés randomisés comme sujet", "alternateName": "Randomized Controlled Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D016032", "about": { "@type": "MedicalCondition", "name": "Essais contrôlés randomisés comme sujet", "code": { "@type": "MedicalCode", "code": "D016032", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Essais d'équivalence comme sujet", "alternateName": "Equivalence Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D000074099", "about": { "@type": "MedicalCondition", "name": "Essais d'équivalence comme sujet", "code": { "@type": "MedicalCode", "code": "D000074099", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.250" } } }, { "@type": "MedicalWebPage", "name": "Analyse en intention de traitement", "alternateName": "Intention to Treat Analysis", "url": "https://questionsmedicales.fr/mesh/D057194", "about": { "@type": "MedicalCondition", "name": "Analyse en intention de traitement", "code": { "@type": "MedicalCode", "code": "D057194", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.500" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques pragmatiques comme sujet", "alternateName": "Pragmatic Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D064792", "about": { "@type": "MedicalCondition", "name": "Essais cliniques pragmatiques comme sujet", "code": { "@type": "MedicalCode", "code": "D064792", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Essais d'équivalence comme sujet", "alternateName": "Equivalence Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D000074099", "about": { "@type": "MedicalCondition", "name": "Essais d'équivalence comme sujet", "code": { "@type": "MedicalCode", "code": "D000074099", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.250" } } }, { "@type": "MedicalWebPage", "name": "Analyse en intention de traitement", "alternateName": "Intention to Treat Analysis", "url": "https://questionsmedicales.fr/mesh/D057194", "about": { "@type": "MedicalCondition", "name": "Analyse en intention de traitement", "code": { "@type": "MedicalCode", "code": "D057194", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.500" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques pragmatiques comme sujet", "alternateName": "Pragmatic Clinical Trials as Topic", "url": "https://questionsmedicales.fr/mesh/D064792", "about": { "@type": "MedicalCondition", "name": "Essais cliniques pragmatiques comme sujet", "code": { "@type": "MedicalCode", "code": "D064792", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.365.500.750" } } }, { "@type": "MedicalWebPage", "name": "Études de cas unique comme sujet", "alternateName": "Single-Case Studies as Topic", "url": "https://questionsmedicales.fr/mesh/D000080907", "about": { "@type": "MedicalCondition", "name": "Études de cas unique comme sujet", "code": { "@type": "MedicalCode", "code": "D000080907", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.250.682" } } }, { "@type": "MedicalWebPage", "name": "Essais cliniques vétérinaires comme sujet", "alternateName": "Clinical Trials, Veterinary as Topic", "url": "https://questionsmedicales.fr/mesh/D000078665", "about": { "@type": "MedicalCondition", "name": "Essais cliniques vétérinaires comme sujet", "code": { "@type": "MedicalCode", "code": "D000078665", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.375" } } }, { "@type": "MedicalWebPage", "name": "Études observationnelles comme sujet", "alternateName": "Observational Studies as Topic", "url": "https://questionsmedicales.fr/mesh/D064887", "about": { "@type": "MedicalCondition", "name": "Études observationnelles comme sujet", "code": { "@type": "MedicalCode", "code": "D064887", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.500" } } }, { "@type": "MedicalWebPage", "name": "Études d'observations vétérinaires comme sujet", "alternateName": "Observational Studies, Veterinary as Topic", "url": "https://questionsmedicales.fr/mesh/D000079223", "about": { "@type": "MedicalCondition", "name": "Études d'observations vétérinaires comme sujet", "code": { "@type": "MedicalCode", "code": "D000079223", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.250.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Études épidémiologiques", "alternateName": "Epidemiologic Studies", "url": "https://questionsmedicales.fr/mesh/D016021", "about": { "@type": "MedicalCondition", "name": "Études épidémiologiques", "code": { "@type": "MedicalCode", "code": "D016021", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Études cas-témoins", "alternateName": "Case-Control Studies", "url": "https://questionsmedicales.fr/mesh/D016022", "about": { "@type": "MedicalCondition", "name": "Études cas-témoins", "code": { "@type": "MedicalCode", "code": "D016022", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.500" } } }, { "@type": "MedicalWebPage", "name": "Études de cohortes", "alternateName": "Cohort Studies", "url": "https://questionsmedicales.fr/mesh/D015331", "about": { "@type": "MedicalCondition", "name": "Études de cohortes", "code": { "@type": "MedicalCode", "code": "D015331", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Études de suivi", "alternateName": "Follow-Up Studies", "url": "https://questionsmedicales.fr/mesh/D005500", "about": { "@type": "MedicalCondition", "name": "Études de suivi", "code": { "@type": "MedicalCode", "code": "D005500", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750.350" } } }, { "@type": "MedicalWebPage", "name": "Études longitudinales", "alternateName": "Longitudinal Studies", "url": "https://questionsmedicales.fr/mesh/D008137", "about": { "@type": "MedicalCondition", "name": "Études longitudinales", "code": { "@type": "MedicalCode", "code": "D008137", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Étude longitudinale sur la santé des adolescents aux États-Unis", "alternateName": "National Longitudinal Study of Adolescent Health", "url": "https://questionsmedicales.fr/mesh/D063588", "about": { "@type": "MedicalCondition", "name": "Étude longitudinale sur la santé des adolescents aux États-Unis", "code": { "@type": "MedicalCode", "code": "D063588", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750.500.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Étude longitudinale sur la santé des adolescents aux États-Unis", "alternateName": "National Longitudinal Study of Adolescent Health", "url": "https://questionsmedicales.fr/mesh/D063588", "about": { "@type": "MedicalCondition", "name": "Étude longitudinale sur la santé des adolescents aux États-Unis", "code": { "@type": "MedicalCode", "code": "D063588", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750.500.500" } } }, { "@type": "MedicalWebPage", "name": "Études prospectives", "alternateName": "Prospective Studies", "url": "https://questionsmedicales.fr/mesh/D011446", "about": { "@type": "MedicalCondition", "name": "Études prospectives", "code": { "@type": "MedicalCode", "code": "D011446", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750.650" } } }, { "@type": "MedicalWebPage", "name": "Études rétrospectives", "alternateName": "Retrospective Studies", "url": "https://questionsmedicales.fr/mesh/D012189", "about": { "@type": "MedicalCondition", "name": "Études rétrospectives", "code": { "@type": "MedicalCode", "code": "D012189", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750.825" } } } ] }, { "@type": "MedicalWebPage", "name": "Études de suivi", "alternateName": "Follow-Up Studies", "url": "https://questionsmedicales.fr/mesh/D005500", "about": { "@type": "MedicalCondition", "name": "Études de suivi", "code": { "@type": "MedicalCode", "code": "D005500", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750.350" } } }, { "@type": "MedicalWebPage", "name": "Études longitudinales", "alternateName": "Longitudinal Studies", "url": "https://questionsmedicales.fr/mesh/D008137", "about": { "@type": "MedicalCondition", "name": "Études longitudinales", "code": { "@type": "MedicalCode", "code": "D008137", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Étude longitudinale sur la santé des adolescents aux États-Unis", "alternateName": "National Longitudinal Study of Adolescent Health", "url": "https://questionsmedicales.fr/mesh/D063588", "about": { "@type": "MedicalCondition", "name": "Étude longitudinale sur la santé des adolescents aux États-Unis", "code": { "@type": "MedicalCode", "code": "D063588", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750.500.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Étude longitudinale sur la santé des adolescents aux États-Unis", "alternateName": "National Longitudinal Study of Adolescent Health", "url": "https://questionsmedicales.fr/mesh/D063588", "about": { "@type": "MedicalCondition", "name": "Étude longitudinale sur la santé des adolescents aux États-Unis", "code": { "@type": "MedicalCode", "code": "D063588", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750.500.500" } } }, { "@type": "MedicalWebPage", "name": "Études prospectives", "alternateName": "Prospective Studies", "url": "https://questionsmedicales.fr/mesh/D011446", "about": { "@type": "MedicalCondition", "name": "Études prospectives", "code": { "@type": "MedicalCode", "code": "D011446", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750.650" } } }, { "@type": "MedicalWebPage", "name": "Études rétrospectives", "alternateName": "Retrospective Studies", "url": "https://questionsmedicales.fr/mesh/D012189", "about": { "@type": "MedicalCondition", "name": "Études rétrospectives", "code": { "@type": "MedicalCode", "code": "D012189", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.750.825" } } }, { "@type": "MedicalWebPage", "name": "Études contrôlées avant-après", "alternateName": "Controlled Before-After Studies", "url": "https://questionsmedicales.fr/mesh/D065187", "about": { "@type": "MedicalCondition", "name": "Études contrôlées avant-après", "code": { "@type": "MedicalCode", "code": "D065187", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.812" } } }, { "@type": "MedicalWebPage", "name": "Études transversales", "alternateName": "Cross-Sectional Studies", "url": "https://questionsmedicales.fr/mesh/D003430", "about": { "@type": "MedicalCondition", "name": "Études transversales", "code": { "@type": "MedicalCode", "code": "D003430", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.875" } } }, { "@type": "MedicalWebPage", "name": "Analyse de série chronologique interrompue", "alternateName": "Interrupted Time Series Analysis", "url": "https://questionsmedicales.fr/mesh/D065186", "about": { "@type": "MedicalCondition", "name": "Analyse de série chronologique interrompue", "code": { "@type": "MedicalCode", "code": "D065186", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.912" } } }, { "@type": "MedicalWebPage", "name": "Études séroépidémiologiques", "alternateName": "Seroepidemiologic Studies", "url": "https://questionsmedicales.fr/mesh/D016036", "about": { "@type": "MedicalCondition", "name": "Études séroépidémiologiques", "code": { "@type": "MedicalCode", "code": "D016036", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.950" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Séroprévalence du VIH", "alternateName": "HIV Seroprevalence", "url": "https://questionsmedicales.fr/mesh/D015528", "about": { "@type": "MedicalCondition", "name": "Séroprévalence du VIH", "code": { "@type": "MedicalCode", "code": "D015528", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.950.375" } } } ] }, { "@type": "MedicalWebPage", "name": "Séroprévalence du VIH", "alternateName": "HIV Seroprevalence", "url": "https://questionsmedicales.fr/mesh/D015528", "about": { "@type": "MedicalCondition", "name": "Séroprévalence du VIH", "code": { "@type": "MedicalCode", "code": "D015528", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.500.950.375" } } } ] }, { "@type": "MedicalWebPage", "name": "Études de faisabilité", "alternateName": "Feasibility Studies", "url": "https://questionsmedicales.fr/mesh/D005240", "about": { "@type": "MedicalCondition", "name": "Études de faisabilité", "code": { "@type": "MedicalCode", "code": "D005240", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.550" } } }, { "@type": "MedicalWebPage", "name": "Études multicentriques comme sujet", "alternateName": "Multicenter Studies as Topic", "url": "https://questionsmedicales.fr/mesh/D015337", "about": { "@type": "MedicalCondition", "name": "Études multicentriques comme sujet", "code": { "@type": "MedicalCode", "code": "D015337", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.643" } } }, { "@type": "MedicalWebPage", "name": "Projets pilotes", "alternateName": "Pilot Projects", "url": "https://questionsmedicales.fr/mesh/D010865", "about": { "@type": "MedicalCondition", "name": "Projets pilotes", "code": { "@type": "MedicalCode", "code": "D010865", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.720" } } }, { "@type": "MedicalWebPage", "name": "Études par échantillonnage", "alternateName": "Sampling Studies", "url": "https://questionsmedicales.fr/mesh/D012494", "about": { "@type": "MedicalCondition", "name": "Études par échantillonnage", "code": { "@type": "MedicalCode", "code": "D012494", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.875" } } }, { "@type": "MedicalWebPage", "name": "Méthode des jumeaux comme sujet", "alternateName": "Twin Studies as Topic", "url": "https://questionsmedicales.fr/mesh/D018433", "about": { "@type": "MedicalCondition", "name": "Méthode des jumeaux comme sujet", "code": { "@type": "MedicalCode", "code": "D018433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.450.900" } } } ], "about": { "@type": "MedicalCondition", "name": "Caractéristiques des études épidémiologiques", "alternateName": "Epidemiologic Study Characteristics", "code": { "@type": "MedicalCode", "code": "D016020", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Tao Li", "url": "https://questionsmedicales.fr/author/Tao%20Li", "affiliation": { "@type": "Organization", "name": "Qiandongnan CDC, Qiandongnan, China." } }, { "@type": "Person", "name": "Ziyi Liu", "url": "https://questionsmedicales.fr/author/Ziyi%20Liu", "affiliation": { "@type": "Organization", "name": "Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China." } }, { "@type": "Person", "name": "Nino Chkhaberidze", "url": "https://questionsmedicales.fr/author/Nino%20Chkhaberidze", "affiliation": { "@type": "Organization", "name": "Ivane Javakhishvili Tbilisi State University, Faculty of Medicine, 1 Ilia Chavchavadze Avenue, Tbilisi 0179, Georgia; National Center for Disease Control and Public Health, Kakheti Highway 99, Tbilisi 0198, Georgia. Electronic address: nino.chkhaberidze@tsu.ge." } }, { "@type": "Person", "name": "Ketevan Axobadze", "url": "https://questionsmedicales.fr/author/Ketevan%20Axobadze", "affiliation": { "@type": "Organization", "name": "Ivane Javakhishvili Tbilisi State University, Faculty of Medicine, 1 Ilia Chavchavadze Avenue, Tbilisi 0179, Georgia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Clinical and Epidemiological Characteristics of Rhabdomyolysis: A Retrospective Study.", "datePublished": "2023-09-29", "url": "https://questionsmedicales.fr/article/37808625", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2023/6396576" } }, { "@type": "ScholarlyArticle", "name": "Epidemiological characteristics of", "datePublished": "2023-07-19", "url": "https://questionsmedicales.fr/article/37538843", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fmicb.2023.1219733" } }, { "@type": "ScholarlyArticle", "name": "Epidemiological Characteristics of", "datePublished": "2023-01-23", "url": "https://questionsmedicales.fr/article/36766513", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/diagnostics13030408" } }, { "@type": "ScholarlyArticle", "name": "Epidemiological characteristics of", "datePublished": "2022-08-31", "url": "https://questionsmedicales.fr/article/36118037", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fcimb.2022.901423" } }, { "@type": "ScholarlyArticle", "name": "Epidemiological characteristics of", "datePublished": "2023-06-28", "url": "https://questionsmedicales.fr/article/37448578", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fmicb.2023.1171350" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Méthodes épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D004812" }, { "@type": "ListItem", "position": 5, "name": "Caractéristiques des études épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D016020" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Caractéristiques des études épidémiologiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Caractéristiques des études épidémiologiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-27", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Caractéristiques des études épidémiologiques", "description": "Qu'est-ce qu'une étude de cohorte ?\nComment une étude cas-témoins est-elle réalisée ?\nQuelle est l'importance des études transversales ?\nQu'est-ce qu'une étude longitudinale ?\nQuel est le rôle des essais cliniques ?", "url": "https://questionsmedicales.fr/mesh/D016020#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Caractéristiques des études épidémiologiques", "description": "Comment les symptômes sont-ils collectés dans les études ?\nQuelle est la méthode d'évaluation des symptômes ?\nPourquoi est-il important de définir les symptômes ?\nComment les symptômes influencent-ils les résultats ?\nQuels outils mesurent les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D016020#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Caractéristiques des études épidémiologiques", "description": "Quelles stratégies de prévention sont courantes ?\nComment évaluer l'efficacité des programmes de prévention ?\nQuel rôle joue l'éducation dans la prévention ?\nComment les facteurs environnementaux influencent-ils la prévention ?\nPourquoi la surveillance épidémiologique est-elle essentielle ?", "url": "https://questionsmedicales.fr/mesh/D016020#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Caractéristiques des études épidémiologiques", "description": "Comment les traitements sont-ils évalués dans les études ?\nQuel est l'impact des traitements sur les résultats ?\nQuelles sont les méthodes de randomisation ?\nPourquoi les études de traitement sont-elles cruciales ?\nComment les effets à long terme des traitements sont-ils étudiés ?", "url": "https://questionsmedicales.fr/mesh/D016020#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Caractéristiques des études épidémiologiques", "description": "Comment les complications sont-elles identifiées dans les études ?\nQuel est l'impact des complications sur les résultats ?\nComment les complications sont-elles classées ?\nPourquoi est-il important de suivre les complications ?\nQuelles méthodes préviennent les complications ?", "url": "https://questionsmedicales.fr/mesh/D016020#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Caractéristiques des études épidémiologiques", "description": "Comment les facteurs de risque sont-ils identifiés ?\nQuel est l'impact des facteurs de risque sur la santé ?\nComment les facteurs de risque sont-ils mesurés ?\nPourquoi est-il crucial d'étudier les facteurs de risque ?\nQuels types de facteurs de risque existent ?", "url": "https://questionsmedicales.fr/mesh/D016020#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Qu'est-ce qu'une étude de cohorte ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Une étude de cohorte suit un groupe sur le temps pour observer l'apparition de maladies." } }, { "@type": "Question", "name": "Comment une étude cas-témoins est-elle réalisée ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elle compare des individus malades à des témoins sains pour identifier des facteurs de risque." } }, { "@type": "Question", "name": "Quelle est l'importance des études transversales ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles évaluent la prévalence d'une maladie à un moment donné dans une population." } }, { "@type": "Question", "name": "Qu'est-ce qu'une étude longitudinale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "C'est une étude qui observe les mêmes sujets sur une période prolongée pour des changements." } }, { "@type": "Question", "name": "Quel est le rôle des essais cliniques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils testent l'efficacité et la sécurité de nouveaux traitements sur des groupes de patients." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils collectés dans les études ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont souvent recueillis via des questionnaires ou des entretiens avec les participants." } }, { "@type": "Question", "name": "Quelle est la méthode d'évaluation des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les échelles de mesure standardisées sont utilisées pour quantifier l'intensité des symptômes." } }, { "@type": "Question", "name": "Pourquoi est-il important de définir les symptômes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une définition claire aide à standardiser les études et à comparer les résultats entre elles." } }, { "@type": "Question", "name": "Comment les symptômes influencent-ils les résultats ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent affecter la qualité de vie et la réponse au traitement, influençant les conclusions." } }, { "@type": "Question", "name": "Quels outils mesurent les symptômes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des outils comme le VAS (Visual Analog Scale) ou le SF-36 sont couramment utilisés." } }, { "@type": "Question", "name": "Quelles stratégies de prévention sont courantes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les campagnes de sensibilisation et les vaccinations sont des stratégies clés de prévention." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des programmes de prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "On utilise des études avant-après pour mesurer l'impact des interventions préventives." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation sensibilise les populations aux risques et aux comportements sains pour prévenir les maladies." } }, { "@type": "Question", "name": "Comment les facteurs environnementaux influencent-ils la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les conditions environnementales peuvent affecter l'accès aux soins et les comportements préventifs." } }, { "@type": "Question", "name": "Pourquoi la surveillance épidémiologique est-elle essentielle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de détecter les épidémies et d'évaluer l'efficacité des mesures de prévention." } }, { "@type": "Question", "name": "Comment les traitements sont-ils évalués dans les études ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont comparés à un groupe témoin pour déterminer leur efficacité et leurs effets secondaires." } }, { "@type": "Question", "name": "Quel est l'impact des traitements sur les résultats ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent améliorer les résultats de santé, mais des effets indésirables peuvent survenir." } }, { "@type": "Question", "name": "Quelles sont les méthodes de randomisation ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La randomisation assure que les groupes de traitement sont comparables, minimisant les biais." } }, { "@type": "Question", "name": "Pourquoi les études de traitement sont-elles cruciales ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elles fournissent des preuves sur l'efficacité des interventions médicales et des protocoles." } }, { "@type": "Question", "name": "Comment les effets à long terme des traitements sont-ils étudiés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des études de suivi à long terme évaluent la durabilité des effets des traitements." } }, { "@type": "Question", "name": "Comment les complications sont-elles identifiées dans les études ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont souvent rapportées par les participants ou détectées par des examens médicaux." } }, { "@type": "Question", "name": "Quel est l'impact des complications sur les résultats ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent aggraver l'état de santé et influencer les décisions de traitement." } }, { "@type": "Question", "name": "Comment les complications sont-elles classées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont classées par gravité et type, facilitant l'analyse des données épidémiologiques." } }, { "@type": "Question", "name": "Pourquoi est-il important de suivre les complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Le suivi aide à comprendre les effets à long terme des maladies et des traitements." } }, { "@type": "Question", "name": "Quelles méthodes préviennent les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des protocoles de soins et des interventions précoces peuvent réduire le risque de complications." } }, { "@type": "Question", "name": "Comment les facteurs de risque sont-ils identifiés ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont souvent déterminés par des études épidémiologiques analysant les données de santé." } }, { "@type": "Question", "name": "Quel est l'impact des facteurs de risque sur la santé ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs de risque augmentent la probabilité de développer certaines maladies ou conditions." } }, { "@type": "Question", "name": "Comment les facteurs de risque sont-ils mesurés ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont mesurés par des questionnaires, des tests biologiques ou des examens cliniques." } }, { "@type": "Question", "name": "Pourquoi est-il crucial d'étudier les facteurs de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Comprendre les facteurs de risque aide à développer des stratégies de prévention efficaces." } }, { "@type": "Question", "name": "Quels types de facteurs de risque existent ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être biologiques, comportementaux, environnementaux ou socio-économiques." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 24/02/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

35 au total
└─

Études cliniques comme sujet

Clinical Studies as Topic D000068456 - N06.850.520.450.250
└─

Études épidémiologiques

Epidemiologic Studies D016021 - N06.850.520.450.500
└─

Études de faisabilité

Feasibility Studies D005240 - N06.850.520.450.550
└─

Études multicentriques comme sujet

Multicenter Studies as Topic D015337 - N06.850.520.450.643
└─

Projets pilotes

Pilot Projects D010865 - N06.850.520.450.720
└─

Études par échantillonnage

Sampling Studies D012494 - N06.850.520.450.875
└─

Méthode des jumeaux comme sujet

Twin Studies as Topic D018433 - N06.850.520.450.900
└─└─

Essais cliniques comme sujet

Clinical Trials as Topic D002986 - N06.850.520.450.250.250
└─└─

Essais cliniques vétérinaires comme sujet

Clinical Trials, Veterinary as Topic D000078665 - N06.850.520.450.250.375
└─└─

Études observationnelles comme sujet

Observational Studies as Topic D064887 - N06.850.520.450.250.500
└─└─

Études d'observations vétérinaires comme sujet

Observational Studies, Veterinary as Topic D000079223 - N06.850.520.450.250.750
└─└─

Études cas-témoins

Case-Control Studies D016022 - N06.850.520.450.500.500
└─└─

Études de cohortes

Cohort Studies D015331 - N06.850.520.450.500.750
└─└─

Études contrôlées avant-après

Controlled Before-After Studies D065187 - N06.850.520.450.500.812
└─└─

Études transversales

Cross-Sectional Studies D003430 - N06.850.520.450.500.875
└─└─

Analyse de série chronologique interrompue

Interrupted Time Series Analysis D065186 - N06.850.520.450.500.912
└─└─

Études séroépidémiologiques

Seroepidemiologic Studies D016036 - N06.850.520.450.500.950
└─└─└─

Essais cliniques adaptatifs comme sujet

Adaptive Clinical Trials as Topic D000075522 - N06.850.520.450.250.250.100
└─└─└─

Essais cliniques de phase I comme sujet

Clinical Trials, Phase I as Topic D017321 - N06.850.520.450.250.250.200
└─└─└─

Essais cliniques de phase II comme sujet

Clinical Trials, Phase II as Topic D017322 - N06.850.520.450.250.250.210
└─└─└─

Essais cliniques de phase III comme sujet

Clinical Trials, Phase III as Topic D017326 - N06.850.520.450.250.250.220
└─└─└─

Essais cliniques de phase IV comme sujet

Clinical Trials, Phase IV as Topic D017327 - N06.850.520.450.250.250.230
└─└─└─

Essais cliniques contrôlés comme sujet

Controlled Clinical Trials as Topic D018849 - N06.850.520.450.250.250.365
└─└─└─

Études de cas unique comme sujet

Single-Case Studies as Topic D000080907 - N06.850.520.450.250.250.682
└─└─└─

Études de suivi

Follow-Up Studies D005500 - N06.850.520.450.500.750.350
└─└─└─

Études longitudinales

Longitudinal Studies D008137 - N06.850.520.450.500.750.500
└─└─└─

Études prospectives

Prospective Studies D011446 - N06.850.520.450.500.750.650
└─└─└─

Études rétrospectives

Retrospective Studies D012189 - N06.850.520.450.500.750.825
└─└─└─

Séroprévalence du VIH

HIV Seroprevalence D015528 - N06.850.520.450.500.950.375
└─└─└─└─

Essais contrôlés non randomisés comme sujet

Non-Randomized Controlled Trials as Topic D065228 - N06.850.520.450.250.250.365.250
└─└─└─└─

Essais contrôlés randomisés comme sujet

Randomized Controlled Trials as Topic D016032 - N06.850.520.450.250.250.365.500
└─└─└─└─

Étude longitudinale sur la santé des adolescents aux États-Unis

National Longitudinal Study of Adolescent Health D063588 - N06.850.520.450.500.750.500.500
└─└─└─└─└─

Essais d'équivalence comme sujet

Equivalence Trials as Topic D000074099 - N06.850.520.450.250.250.365.500.250
└─└─└─└─└─

Analyse en intention de traitement

Intention to Treat Analysis D057194 - N06.850.520.450.250.250.365.500.500
└─└─└─└─└─

Essais cliniques pragmatiques comme sujet

Pragmatic Clinical Trials as Topic D064792 - N06.850.520.450.250.250.365.500.750

Auteurs principaux

Tao Li

2 publications dans cette catégorie

Affiliations :
  • Qiandongnan CDC, Qiandongnan, China.
Publications dans "Caractéristiques des études épidémiologiques" :

Ziyi Liu

2 publications dans cette catégorie

Affiliations :
  • Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China.
  • Institute of Comparative Medicine, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China.
Publications dans "Caractéristiques des études épidémiologiques" :

Nino Chkhaberidze

2 publications dans cette catégorie

Affiliations :
  • Ivane Javakhishvili Tbilisi State University, Faculty of Medicine, 1 Ilia Chavchavadze Avenue, Tbilisi 0179, Georgia; National Center for Disease Control and Public Health, Kakheti Highway 99, Tbilisi 0198, Georgia. Electronic address: nino.chkhaberidze@tsu.ge.

Ketevan Axobadze

2 publications dans cette catégorie

Affiliations :
  • Ivane Javakhishvili Tbilisi State University, Faculty of Medicine, 1 Ilia Chavchavadze Avenue, Tbilisi 0179, Georgia.

Nato Pitskhelauri

2 publications dans cette catégorie

Affiliations :
  • Ivane Javakhishvili Tbilisi State University, Faculty of Medicine, 1 Ilia Chavchavadze Avenue, Tbilisi 0179, Georgia.

Nino Chikhladze

2 publications dans cette catégorie

Affiliations :
  • Ivane Javakhishvili Tbilisi State University, Faculty of Medicine, 1 Ilia Chavchavadze Avenue, Tbilisi 0179, Georgia.

Chang Liu

2 publications dans cette catégorie

Affiliations :
  • Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Publications dans "Caractéristiques des études épidémiologiques" :

Xiaoli Cao

2 publications dans cette catégorie

Affiliations :
  • Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Publications dans "Caractéristiques des études épidémiologiques" :

Han Shen

2 publications dans cette catégorie

Affiliations :
  • Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Publications dans "Caractéristiques des études épidémiologiques" :

J X Chen

2 publications dans cette catégorie

Affiliations :
  • National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China.
Publications dans "Caractéristiques des études épidémiologiques" :

L G Tian

2 publications dans cette catégorie

Affiliations :
  • National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, National Research Center for Tropical Diseases, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China.
Publications dans "Caractéristiques des études épidémiologiques" :

Shuo Liu

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital and Institute, Beijing, China.

Huichao Li

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital and Institute, Beijing, China.

Lei Yang

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital and Institute, Beijing, China.

Xi Zhang

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital and Institute, Beijing, China.

Qingyu Li

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital and Institute, Beijing, China.

Haoxin Li

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital and Institute, Beijing, China.

Ning Wang

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital and Institute, Beijing, China.

Emmanuel Bottieau

2 publications dans cette catégorie

Affiliations :
  • Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Sources (10000 au total)

Clinical and Epidemiological Characteristics of Rhabdomyolysis: A Retrospective Study.

Rhabdomyolysis (RM) refers to a clinical syndrome in which muscle cells are damaged by various causes and the clinical manifestations are mainly muscle pain, weakness, and dark urine. Acute kidney inj... Analysis of medical records of RM patients admitted to Tianjin Medical University General Hospital from October 2019 to October 2022. Statistical software SPSS 25.0 was used to analyze the data. The r... Among the 71 patients, the median age of the patients was 53.0 (30.0, 71.0) years and was 2.5 times higher in men than in women. Infection was the most common etiology. History of alcohol consumption,... Our study revealed the clinical and laboratory characteristics of RM in the population attending the Tianjin Medical University General Hospital in the last three years, which is a reference for futur...

Epidemiological characteristics of

Herein, we tested the hypothesis that Asymptomatic... Between 2018 - 2021, we conducted 11 population screenings (PS, Day 0 (D0)) in 13 different riverine communities around Iquitos city, in the Peruvian Amazon, to identify Pv Sym and Asym individuals. A... From the 2159 individuals screened during PS, data revealed a low but heterogeneous Pv prevalence across the communities (11.4%), where most infections were Asym (66.7%) and submicroscopic (82.9%). A ... For the first-time, key epidemiological, hematological, and biochemical features are reported from Pv Asym infections from the Peruvian Amazon. These results should be considered for the design and re...

Molecular epidemiological characteristics of

The present study analyzed the impact of the COVID-19 pandemic on the prevalence and incidence of new leprosy cases, as well as the diversity, distribution, and temporal transmission of... A total of 219 new leprosy cases during two periods, 2018-2019 and 2020-2021, were compared. We genetically characterized 83 clinical isolates of... There was an 18.97% decrease in the number of counties and districts reporting cases. Considering the initial months (January-March) of virus emergence, the number of new cases in 2021 increased by 16... COVID-19 may have a negative/imbalanced impact on the prevention and control measures of leprosy, which could be a considerable fact for official health departments. Isolates formed clusters among cou...

Molecular epidemiological characteristics of

Brucellosis was made statutorily notifiable in 1955, in China, while in Guizhou Province, the pathogen of human brucellosis was isolated for the first time in 2011. However, currently, the brucellosis... MLST, MLVA, and... Among the 83... MLVA has a high resolution, but differences at the Bruce 04 and 16 loci cannot exclude associations between epidemics, and combining MLST and...

Epidemiological and Molecular Characteristics of

Carbapenem-resistant... In this study, Multiplex polymerase chain reaction (PCR) was performed to detect the carbapenem-resistant genes, and the broth microdilution method was used to determine the minimum inhibitory concent... All strains exhibited resistance to carbapenems and other antibiotics. However, they were still susceptible to polymyxin E. Among them, 18 isolates were positive for... These findings suggested that ST11-KL64 CRKP strains are major threats in terms of nosocomial infections in this hospital. Hence, new strategies should be urgently developed to monitor, diagnose, and ...